304 related articles for article (PubMed ID: 18951462)
1. Mechanisms of pathogenicity in human MSH2 missense mutants.
Ollila S; Dermadi Bebek D; Jiricny J; Nyström M
Hum Mutat; 2008 Nov; 29(11):1355-63. PubMed ID: 18951462
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
3. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
4. MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression system.
Belvederesi L; Bianchi F; Galizia E; Loretelli C; Bracci R; Catalani R; Amati M; Cellerino R
Hum Mutat; 2008 Nov; 29(11):E296-309. PubMed ID: 18781619
[TBL] [Abstract][Full Text] [Related]
5. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.
Ollila S; Sarantaus L; Kariola R; Chan P; Hampel H; Holinski-Feder E; Macrae F; Kohonen-Corish M; Gerdes AM; Peltomäki P; Mangold E; de la Chapelle A; Greenblatt M; Nyström M
Gastroenterology; 2006 Nov; 131(5):1408-17. PubMed ID: 17101317
[TBL] [Abstract][Full Text] [Related]
6. A database to support the interpretation of human mismatch repair gene variants.
Ou J; Niessen RC; Vonk J; Westers H; Hofstra RM; Sijmons RH
Hum Mutat; 2008 Nov; 29(11):1337-41. PubMed ID: 18951442
[TBL] [Abstract][Full Text] [Related]
7. A novel missense MSH2 gene mutation in a patient of a Korean family with hereditary nonpolyposis colorectal cancer.
Park SJ; Lee KA; Park TS; Kim NK; Song J; Kim BY; Choi JR
Cancer Genet Cytogenet; 2008 Apr; 182(2):136-9. PubMed ID: 18406877
[TBL] [Abstract][Full Text] [Related]
8. The importance of functional testing in the genetic assessment of Muir-Torre syndrome, a clinical subphenotype of HNPCC.
Ollila S; Fitzpatrick R; Sarantaus L; Kariola R; Ambus I; Velsher L; Hsieh E; Andersen MK; Raevaara TE; Gerdes AM; Mangold E; Peltomäki P; Lynch HT; Nyström M
Int J Oncol; 2006 Jan; 28(1):149-53. PubMed ID: 16327991
[TBL] [Abstract][Full Text] [Related]
9. Uncertain pathogenicity of MSH2 variants N127S and G322D challenges their classification.
Ollila S; Dermadi Bebek D; Greenblatt M; Nyström M
Int J Cancer; 2008 Aug; 123(3):720-4. PubMed ID: 18470917
[TBL] [Abstract][Full Text] [Related]
10. Classification of mismatch repair gene missense variants with PON-MMR.
Ali H; Olatubosun A; Vihinen M
Hum Mutat; 2012 Apr; 33(4):642-50. PubMed ID: 22290698
[TBL] [Abstract][Full Text] [Related]
11. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
12. [Mismatch repair (MMR) efficiency and MSH2 gene mutation in human colorectal carcinoma cell line COLO320HSR].
Tronov VA; Kramarenko II; Maĭorova EN; Zakharov SF
Genetika; 2007 Apr; 43(4):537-44. PubMed ID: 17555131
[TBL] [Abstract][Full Text] [Related]
13. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.
Gammie AE; Erdeniz N; Beaver J; Devlin B; Nanji A; Rose MD
Genetics; 2007 Oct; 177(2):707-21. PubMed ID: 17720936
[TBL] [Abstract][Full Text] [Related]
15. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
[TBL] [Abstract][Full Text] [Related]
16. New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife.
Medina-Arana V; Barrios Y; Fernández-Peralta A; Herrera M; Chinea N; Lorenzo N; Jiménez A; Martín-López JV; González-Hermoso F; Salido E; González-Aguilera JJ
Cancer Lett; 2006 Dec; 244(2):268-73. PubMed ID: 16500024
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity of A600V variant in exon 12 of the MSH2 gene detected in a Japanese kindred with Lynch syndrome.
Miyakura Y; Sugano K; Nomizu T; Lefor A; Yasuda Y
Jpn J Clin Oncol; 2012 Jan; 42(1):78-82. PubMed ID: 22086974
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the mismatch repair defect in the human lymphoblastoid MT1 cells.
Szadkowski M; Iaccarino I; Heinimann K; Marra G; Jiricny J
Cancer Res; 2005 Jun; 65(11):4525-9. PubMed ID: 15930269
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of DNA mismatch repair enzyme MSH2 is not correlated with prognostic data from endometrial carcinomas.
Schröer A; Köster F; Fischer D; Dubitscher RM; Woll-Hermann A; Diedrich K; Friedrich M; Salehin D
Anticancer Res; 2009 Nov; 29(11):4833-7. PubMed ID: 20032443
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
